Ethanol-induced disruption of kinase signaling pathways in brain development
乙醇诱导大脑发育中激酶信号通路的破坏
基本信息
- 批准号:10366867
- 负责人:
- 金额:$ 36.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:ActinsAcuteAdaptor Signaling ProteinAlcoholsAxonBiochemicalBiologicalBrainCellsCenters for Disease Control and Prevention (U.S.)ChildCritical PathwaysDefectDendritesDevelopmentDiseaseDissectionDoseElementsEmbryoEnzymesEthanolEthanol dependenceEtiologyEventFetal Alcohol ExposureFetal Alcohol SyndromeFutureGeneticGenetic Predisposition to DiseaseGenetic studyGoalsGolgi ApparatusGrowthIn VitroIntellectual functioning disabilityKnock-outLigand BindingLigandsLive BirthLocationMembraneMethodologyMolecularMolecular TargetMorphologyMultipolar NeuronMusNervous system structureNeuronal DifferentiationNeuronsPhasePhosphorylationPhosphotransferasesPositioning AttributeProtein DephosphorylationProtein Tyrosine KinaseProteinsReceptor Protein-Tyrosine KinasesReelin Signaling PathwayResearch PersonnelRoleSignal PathwaySignal TransductionSiteStructureSynaptic plasticitySyndromeTeratogenic effectsTestingTyrosine PhosphorylationUnited Statesalcohol consumption during pregnancyalcohol effectalcohol exposurealcohol researchalcohol responseaxon growthaxonal pathfindingcofilinfetalglycosylationin vivomaternal alcohol usemind controlnovelpostnatalpreventreceptorreceptor bindingresponsesrc-Family Kinasessynaptic functionwhite matter
项目摘要
ABSTRACT
Fetal Alcohol Syndrome (FAS) is one of the leading causes of intellectual disability in the United States. The
CDC estimates that 0.2-1.5 per 1000 live births are children with FASD, a syndrome characterized by disrupted
fetal brain development and postnatal intellectual disability (ID). Disrupted connectivity including altered
dendritic structure, axonal pathfinding and white matter tracts are common findings in FAS and are thought to
be major contributors to ID. However, the cellular and biological targets of alcohol are diverse and it is not clear
whether there are common underlying molecular mechanisms producing these disruptions. Identification of
common molecular mechanism(s) would enable a deeper understanding of this disorder, inform studies of
genetic susceptibilities and provide molecular targets for neuroprotective strategies. This proposal pursues our
finding that acute ethanol (EtOH) exposure disrupts Src kinase activity in embryonic cortical neurons. Src is a
critical non-receptor tyrosine kinase that sits at central positions in multiple signaling pathways including the
Reelin-Dab1 signaling pathway which controls brain layer formation and dendritogenesis. We found that acute
EtOH exposure activates Src and induces phosphorylation of many proteins including Dab1, an essential
adaptor protein in the Reelin-signaling pathway. Remarkably, this dramatic increase in phosphorylation is
followed by a sustained dephosphorylation response in which the phosphorylation of Reelin effectors including
Dab1, Src itself and the actin severing protein n-cofilin return to baseline levels, or below. During the extended
dephosphorylation phase, the Reelin-signaling pathway can no longer be activated by in vitro application of its
ligand, Reelin. In AIM 1 of this proposal, we will determine whether Reelin-Dab1 silencing occurs in vivo after
maternal dosing with EtOH. We will then determine whether genetic deficiency in Src prevents the
phosphorylation and dephosphorylation responses. Genetically establishing the critical kinase that initiates the
EtOH response in vivo will be essential for future neuroprotective efforts. We and others have shown that
Reelin-Dab1 signaling controls Golgi-deployment in the forming dendrite. In AIM 2 we will examine whether Src
activation and inactivation disrupts Golgi location and function. Disrupted Golgi function would be expected to
impact membrane addition, glycosylation, secretion and appropriate expression of many proteins, with
potential long term negative consequences on neuritogenesis and neuronal function. In AIM 3 we will
determine whether the EphA3 signaling pathway is similarly disrupted by Src dysregulation. EphA3 is a
receptor tyrosine kinase that is required for axonal and white matter tract development. We identified the
activation site of EphA3 as a target of EtOH-induced Src dysregulation raising the possibility that EphA3
activation and then silencing may contribute to FASD-related white matter disruptions. Collectively, these
studies will determine the contribution of EtOH-dependent Src dysregulation to altered developmental signaling
in pathways critical for brain development.
摘要
胎儿酒精综合征(FAS)是美国智力残疾的主要原因之一。的
CDC估计,每1000名活产婴儿中有0.2 - 1.5名患有FASD,这是一种以破坏性发育为特征的综合征。
胎儿脑发育和出生后智力残疾(ID)。连接中断,包括改变
树突状结构、轴突寻路和白色物质束是FAS的常见发现,
然而,酒精的细胞和生物靶点是多种多样的,目前还不清楚。
是否有共同的潜在分子机制产生这些破坏。鉴定
共同的分子机制将使人们能够更深入地了解这种疾病,
遗传易感性并为神经保护策略提供分子靶点。这项建议追求我们的
发现急性乙醇(EtOH)暴露会破坏胚胎皮层神经元中Src激酶的活性。src是
一种重要的非受体酪氨酸激酶,位于多种信号通路的中心位置,包括
Reelin-Dab1信号通路控制脑层形成和树突状细胞生成。我们发现急性
EtOH暴露激活Src并诱导许多蛋白质的磷酸化,包括Dab 1,一种必需的蛋白质。
接头蛋白在Reelin信号通路。值得注意的是,这种磷酸化的急剧增加,
随后是持续的去磷酸化反应,其中包括
Dab1、Src本身和肌动蛋白切割蛋白n-cofilin恢复到基线水平或更低。在延长
在去磷酸化阶段,Reelin信号通路不能再通过体外应用其
配体,Reelin。在本建议的AIM 1中,我们将确定在体内是否发生Reelin-Dab1沉默,
母体给药EtOH。然后我们将确定Src基因缺陷是否会阻止
磷酸化和去磷酸化反应。从遗传学上建立起启动
体内EtOH反应将是未来神经保护工作的关键。我们和其他人已经证明,
Reelin-Dab1信号控制高尔基体在树突形成中的部署。在AIM 2中,我们将检查Src是否
激活和失活破坏了高尔基体的位置和功能。高尔基体功能的破坏
影响膜添加、糖基化、分泌和许多蛋白质的适当表达,
对轴突发生和神经元功能的潜在长期负面后果。在AIM 3中,
确定EphA3信号通路是否类似地被Src失调破坏。EphA3是一种
轴突和白色物质束发育所需的受体酪氨酸激酶。我们确定了
EphA3的激活位点作为EtOH诱导的Src失调的靶点,这提高了EphA3
激活然后沉默可能导致FASD相关的白色物质破坏。总的来说,这些
研究将确定EtOH依赖性Src失调对发育信号改变的贡献
大脑发育的关键途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC Christopher OLSON其他文献
ERIC Christopher OLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC Christopher OLSON', 18)}}的其他基金
Ethanol-induced disruption of kinase signaling pathways in brain development
乙醇诱导大脑发育中激酶信号通路的破坏
- 批准号:
10706460 - 财政年份:2022
- 资助金额:
$ 36.68万 - 项目类别:
Cellular and Molecular Mechanisms of Early Cortical Development
早期皮质发育的细胞和分子机制
- 批准号:
8520056 - 财政年份:2009
- 资助金额:
$ 36.68万 - 项目类别:
Cellular and Molecular Mechanisms of Early Cortical Development
早期皮质发育的细胞和分子机制
- 批准号:
8309326 - 财政年份:2009
- 资助金额:
$ 36.68万 - 项目类别:
Cellular and Molecular Mechanisms of Early Cortical Development
早期皮质发育的细胞和分子机制
- 批准号:
7700139 - 财政年份:2009
- 资助金额:
$ 36.68万 - 项目类别:
Cellular and Molecular Mechanisms of Early Cortical Development
早期皮质发育的细胞和分子机制
- 批准号:
8118029 - 财政年份:2009
- 资助金额:
$ 36.68万 - 项目类别:
Project 1 - Developmental Exposure Alcohol Research Center
项目 1 - 发育性酒精暴露研究中心
- 批准号:
8381958 - 财政年份:
- 资助金额:
$ 36.68万 - 项目类别:
Ethanol and Reelin-dependent Plasticity During Fetal and Adolescent Periods
胎儿和青少年时期乙醇和 Reelin 依赖性可塑性
- 批准号:
8599557 - 财政年份:
- 资助金额:
$ 36.68万 - 项目类别:
Project 1 - Developmental Exposure Alcohol Research Center
项目 1 - 发育性酒精暴露研究中心
- 批准号:
8326843 - 财政年份:
- 资助金额:
$ 36.68万 - 项目类别:
Project 1 - Developmental Exposure Alcohol Research Center
项目 1 - 发育性酒精暴露研究中心
- 批准号:
8537096 - 财政年份:
- 资助金额:
$ 36.68万 - 项目类别:
Ethanol and Reelin-dependent Plasticity During Fetal and Adolescent Periods
胎儿和青少年时期乙醇和 Reelin 依赖性可塑性
- 批准号:
9323204 - 财政年份:
- 资助金额:
$ 36.68万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
Operating Grants














{{item.name}}会员




